A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial
JMIR Research Protocols · 27.01.2026 · 15 · e86413
DOI: 10.2196/86413 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, online erschienen am 27.01.2026. Verfasst von Anna Julià und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fundació Sanitària d'Igualada, Igualada, Spain. Hauptthemen laut MEDLINE: Self-Injurious Behavior, Mobile Applications, Smartphone, Psychosocial Intervention. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Nonsuicidal self-injury (NSSI), defined as the deliberate, self-inflicted damage of body tissue without suicidal intent, is increasingly prevalent among adolescents and young adults and poses a major public health concern. Current treatments are often costly, difficult to access, and not tailored to the specific needs of young people. Mobile health (mHealth) interventions represent a promising avenue for scalable, accessible, and cost-effective support for NSSI, especially when combined with real-time assessments and personalized treatment strategies.
Objective
This randomized controlled trial will evaluate the effectiveness of Kalmer, a brief app-based intervention for reducing NSSI and improving emotional well-being. The study has 2 aims: (1) to evaluate a newly developed app-based intervention for adolescents and young adults engaging in NSSI and (2) to assess predictors of treatment outcomes for this app-based intervention. We hypothesize that participants receiving a mobile app–based brief intervention specifically tailored to address NSSI will show a greater reduction in NSSI frequency at the end of treatment and at follow-up than participants receiving a nonspecific app-based intervention. In this paper, we present our study protocol.
Methods
This 2-arm randomized controlled trial, lasting 6 weeks, will include 240 participants aged 14 to 24 years who engage in NSSI. The intervention app, Kalmer, was developed through iterative consultation with clinical and research experts and guided by survey results and evidence-based frameworks such as dialectical behavior therapy and cognitive behavioral therapy. The intervention will include 5 core components: distress tolerance, emotion regulation, mindfulness and self-compassion, interpersonal regulation, and problem-focused coping. The app will deliver multimedia-based ecological momentary interventions triggered by real-time ecological momentary assessments to tailor support to users’ current contexts and needs. Participants are randomized to receive either the Kalmer intervention or a psychoeducational control app. The primary outcome will be NSSI frequency, assessed through self-report at baseline, 6 weeks after intervention, and at 1-month and 3-month follow-ups.
Results
Ethics approval was obtained in December 2022. As of January 2026, a total of 145 participants had consented to participate in the study and completed baseline assessments. Preliminary data show high app engagement and acceptability and positive user feedback regarding app usability and content. Recruitment is ongoing.
Conclusions
This study will provide evidence on the effectiveness of a mobile app–based intervention for NSSI and will explore potential mechanisms of change, supporting the development of accessible digital mental health tools for adolescents and young adults. Trial Registration International Standard Randomized Controlled Trial Number Registry ISRCTN63093907; https://www.isrctn.com/ISRCTN63093907 International Registered Report Identifier (IRRID) DERR1-10.2196/86413
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fundació Sanitària d'Igualada, Igualada, Spain.
- Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Department of Psychiatry, Hospital Universitari d'Igualada, Consorci Sanitari de l'Anoia, Igualada, Spain.
- Department of Developmental, Educational, Social and Methodology Psychology, Universitat Jaume I, Castellón de la Plana, Spain.
- Department of Basic and Clinical Psychology and Psychobiology, Universitat Jaume I, Castellón de la Plana, Spain.
- CIBER de Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Anna Julià, Irene Jaén, Mónica Conesa Giménez, Azucena García-Palacios, Juan C Pascual, Anna Sintes Estévez, Anaís Lara, Iria Méndez, Soledad Romero, Joaquim Puntí, Joaquim Soler, Jordi Solé-Casals, Marina López-Solà, Daniel Vega
Zitieren
APA
Julià, A., Jaén, I., Conesa Giménez, M., García-Palacios, A., Pascual, J. C., Sintes Estévez, A., Lara, A., Méndez, I., Romero, S., Puntí, J., Soler, J., Solé-Casals, J., López-Solà, M., & Vega, D. (2026). A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial. JMIR Research Protocols, 15, e86413. https://doi.org/10.2196/86413
Vancouver
Julià A, Jaén I, Conesa Giménez M, García-Palacios A, Pascual JC, Sintes Estévez A, et al. A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e86413. doi:10.2196/86413
BibTeX
@article{Juli2026,
author = {Julià, Anna and Jaén, Irene and Conesa Giménez, Mónica and García-Palacios, Azucena and Pascual, Juan C and Sintes Estévez, Anna and Lara, Anaís and Méndez, Iria and Romero, Soledad and Puntí, Joaquim and Soler, Joaquim and Solé-Casals, Jordi and López-Solà, Marina and Vega, Daniel},
title = {A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2026},
volume = {15},
pages = {e86413},
doi = {10.2196/86413}
}
EUVIMED